What Has Been The Evolution of the Infectious Disease Diagnostics Testing Market in Recent Years?
The infectious disease diagnostics testing market has seen considerable growth due to a variety of factors.
• The infectious disease diagnostics testing market has grown rapidly in recent years. It will grow from $38.52 billion in 2024 to $42.56 billion in 2025, reflecting a CAGR of 10.5%.
The growth is due to rising disease outbreaks such as SARS, Ebola, and Zika, increased awareness about early detection and prevention, government-funded disease surveillance programs, global travel, and rising healthcare spending, particularly in emerging markets.
How Will the Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testing market is expected to maintain its strong growth trajectory in upcoming years.
• The infectious disease diagnostics testing market is projected to reach $62.58 billion by 2029 at a CAGR of 10.1%.
This growth is driven by the emergence of new pathogens, personalized medicine, increasing demand for rapid testing, focus on epidemiological surveillance, and R&D investments. Trends include miniaturization of devices, multiplex assays, digital health solutions, next-gen sequencing technologies, biosensor innovations, and AI integration.
Which Factors Are Boosting Growth In The Infectious Disease Diagnostics Testing Market?
The rise in respiratory infections is projected to drive the infectious disease diagnostic testing market. Respiratory infections, often caused by viruses or bacteria, are increasing due to poor hygiene, close contact, and seasonal weather changes. Diagnostic testing is vital for identifying the pathogens causing respiratory infections. According to the Canadian Institute for Health Information, hospitalizations for upper respiratory infections increased by 32% from 2022 to 2023. As a result, the rise in respiratory infections is contributing to the growth of the infectious disease diagnostic testing market.
What Key Areas Define The Segmentation Of The Global Infectious Disease Diagnostics Testing Market?
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
Subsegments:
1) By Molecular Diagnostic Test: Polymerase Chain Reaction (PCR) Tests, Nucleic Acid Amplification Tests (NAATs), Next-Generation Sequencing (NGS), Microarray-Based Tests
2) By Point Of Care Tests (POCT) Infectious Disease Diagnostics Test: Lateral Flow Assays, Rapid Antigen Tests, Immunoassays, Portable PCR
Pre-Book The Infectious Disease Diagnostics Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Infectious Disease Diagnostics Testing Market?
Leading organizations in the infectious disease diagnostic testing market are prioritizing the advancement of inventive technologies, like molecular diagnostics platforms, to maintain their market dominance. These platforms, geared towards nucleic acids (DNA or RNA) detection and analysis from biological specimens for diagnosis, are incredibly advanced. An example of this is Becton Dickinson and Company, an American medical technology firm, which introduced the BD COR System in May 2022 - a full-scale, high-throughput infectious disease molecular diagnostics platform. The platform offers end-to-end automation from sample management to diagnosis, which eliminates the need for manual specimen categorization and allows lab technicians to focus on more critical tasks. Capable of processing as many as 1,700 specimens and providing results in a day, the system offers advanced genotyping for diseases like HPV and STIs along with high-throughput features.
Who Are the Key Players In The Infectious Disease Diagnostics Testing Market?
Major companies operating in the infectious disease diagnostics testing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Danaher Corporation
• Siemens Healthineers AG
• Becton Dickinson And Company
• Quest Diagnostics Incorporated
• Grifols S.A.
• Hologic Inc.
• PerkinElmer Inc.
• bioMérieux SA
• Quidel Corporation
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• DiaSorin SpA (Luminex)
• Myriad Genetics Inc.
• Seegene Inc.
• Ortho Clinical Diagnostics Inc.
• OraSure Technologies Inc.
• Meridian Bioscience Inc.
• Trinity Biotech PLC
• Biodesix Inc.
• Helix OpCo LLC
• Inovio Pharmaceuticals Inc.
What Is The Most Dominant Region In The Infectious Disease Diagnostics Testing Market?
North America was the largest region in the infectious disease diagnostics testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infectious disease diagnostics testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
